Treating Metastatic Breast Cancer with Abemaciclib

Dear Dr. Renukaprasad A R, Abemaciclib is an oral cyclin-dependent kinase 4 and 6 inhibitor which has been shown to improve the survival outcomes in advanced or metastatic forms of breast cancers in the MonarchE trial. It has also been shown to reduce the rate of recurrence among breast cancer patients. Join us TODAY from 08:30 PM to 09:30 PM IST to get deeper insights into abemaciclib! We look forward to your active participation in this information-packed discussion! Highlights: Opening remarks by Dr. Shyam Aggarwal Abemaciclib benefits beyond treatment completion by Dr.Aydah Al Awadhi Updates from ESMO 2022 by Dr. Emad Anwar Case discussion by Dr.Shyam Aggarwal Closing and summary by Dr. Shyam Aggarwal Join Now Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*